View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View Generic ICR - OIRA Conclusion
OMB Control No:
0910-0876
ICR Reference No:
202203-0910-003
Status:
Historical Active
Previous ICR Reference No:
201908-0910-004
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CFSAN
Title:
Generic Clearance for Quick Turnaround Testing of Communication Effectiveness
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
10/28/2022
Retrieve Notice of Action (NOA)
Date Received in OIRA:
08/25/2022
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
10/31/2025
36 Months From Approved
10/31/2022
Responses
39,468
0
93,288
Time Burden (Hours)
4,836
0
10,881
Cost Burden (Dollars)
0
0
529,699
Abstract:
This information collection request supports the creation of an information collection for the development of a “Generic Clearance for Quick Turnaround Testing of Communication Effectiveness.” Section 1003(d)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 393(d)(2)) of the Federal Food, Drug, and Cosmetic Act authorizes the FDA to conduct food research and educational and public information programs relating to the safety of the nation’s food supply. The generic studies covered by this request will be used to test FDA communications and educational messages related to FDA-regulated food and cosmetic products, dietary supplements, and animal food and feed when there is a need for a quick OMB clearance turnaround during matters requiring urgent public health communications. Collecting information from consumers and other stakeholders during urgent public health matters will help ensure that FDA’s messaging has reached the target audience and has been understood. Data will be collected using self-report web-based surveys, focus groups, and one-on-one in-depth interviews.
Authorizing Statute(s):
US Code:
21 USC 393(d)(2)
Name of Law: FD&C Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
87 FR 22906
04/18/2022
30-day Notice:
Federal Register Citation:
Citation Date:
87 FR 51995
08/24/2022
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
4
IC Title
Form No.
Form Name
Focus Groups on Food Recall Communication Effectiveness (CFSAN)
Quick Turnaround Survey on 2023 Applesauce Pouches Recall
Quick Turnaround Testing of Communication Effectiveness - Survey on 2023 Hepatitis A Virus Infections/Frozen Strawberry Recall
Quick Turnaround Testing of Communication Effectiveness - Survey on 2023 Salmonella Infantis/Gold Medal Flour Recall (CFSAN)
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
39,468
93,288
0
0
-53,820
0
Annual Time Burden (Hours)
4,836
10,881
0
0
-6,045
0
Annual Cost Burden (Dollars)
0
529,699
0
0
-529,699
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Our estimated burden for the information collection reflects an overall decrease of 53,820 responses and corresponding decrease of 6,045 hours. We have also removed costs in ROCIS that were erroneously entered in our previous submission.
Annual Cost to Federal Government:
$952,431
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
08/25/2022
An official website of the United States government
The .gov means it's official.
The site is secure.
